Blog Topic
Compounds & Peptides
Profiles of individual research compounds and peptides — mechanism, the published evidence base, and how each is studied alongside incretin therapy. Research-grade compounds referenced are sold strictly for laboratory and in-vitro use only.
Compounds & Peptides
The Problem Nobody Talks About When Patients Start GLP-1 Therapy A 52-year-old male patient starts semaglutide at 0.25 mg/week. By week 12, he's down 18 pounds — but he's also reporting a nagging…
Stay Informed
Get evidence-based research updates and treatment-landscape guides delivered to your inbox.